Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Total Current Liabilities (2020 - 2025)

Celularity (CELU) has disclosed Total Current Liabilities for 6 consecutive years, with $65.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Current Liabilities fell 14.25% to $65.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $65.3 million, a 14.25% decrease, with the full-year FY2024 number at $53.7 million, down 20.24% from a year prior.
  • Total Current Liabilities was $65.3 million for Q3 2025 at Celularity, down from $69.2 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $84.6 million in Q3 2023 to a low of $5.2 million in Q1 2021.
  • A 5-year average of $52.6 million and a median of $65.0 million in 2023 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: soared 20571.7% in 2021, then fell 20.24% in 2024.
  • Celularity's Total Current Liabilities stood at $26.2 million in 2021, then skyrocketed by 136.75% to $62.1 million in 2022, then rose by 8.39% to $67.3 million in 2023, then dropped by 20.24% to $53.7 million in 2024, then rose by 21.67% to $65.3 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Total Current Liabilities are $65.3 million (Q3 2025), $69.2 million (Q2 2025), and $58.7 million (Q1 2025).